---
title: "BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal Investments"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299486654.md"
description: "BioStem Technologies established a $40 million committed equity facility with Roth Principal Investments, effective September 18, 2026. The facility allows BioStem to sell common stock over 36 months for working capital and general corporate purposes. Key terms include VWAP-based pricing with discounts, a $1.00 threshold price, and ownership caps. BioStem will pay a $400,000 commitment fee. Additionally, a Registration Rights Agreement enables the resale registration of up to 12,050,000 shares."
datetime: "2026-09-18T20:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299486654.md)
  - [en](https://longbridge.com/en/news/299486654.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299486654.md)
generator: "portal-rs"
---

# BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal Investments

BioStem Technologies entered a $40 million committed equity facility with Roth Principal Investments and a related Registration Rights Agreement. The facility allows the company, at its discretion, to sell common stock over up to 36 months from Commencement, with purchases priced off VWAP at fixed discounts and subject to a $1.00 threshold price, a 19.99% Nasdaq exchange cap unless priced above a threshold, and a 4.99% ownership cap. BioStem will pay a $400,000 cash commitment fee and expects to use proceeds for working capital and general corporate purposes. The registration rights provide for the resale registration of up to 12,050,000 shares and are required for the facility to commence.

**Agreement 1: BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal Investments**

-   **Agreement type**: Committed equity facility via Common Stock Purchase Agreement
-   **Counterparty**: Roth Principal Investments
-   **Signed / Effective**: Sep 18 2026 / same
-   **Duration / Termination**: Up to 36 months from Commencement
-   **Reason**: Enhance liquidity and fund general corporate purposes

**Agreement 2: BioStem Technologies Sets Registration Rights Deal to Register Up to 12.05M Shares**

-   **Agreement type**: Registration Rights Agreement for resale of up to 12,050,000 shares
-   **Counterparty**: Roth Principal Investments
-   **Signed / Effective**: Sep 18 2026 / same
-   **Duration / Termination**: Survives facility termination
-   **Reason**: Enable resale registration to support equity facility

Original SEC Filing: BioStem Technologies, Inc. \[ BSEM \] - 8-K - Sep. 18, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BSEM.US](https://longbridge.com/en/quote/BSEM.US.md)

## Related News & Research

- [BioStem secures USD 40 million equity facility via private placement with Roth affiliate](https://longbridge.com/en/news/299437694.md)
- [BioStem Technologies joins Terminal1 investor relations platform](https://longbridge.com/en/news/299680877.md)
- [5-Star Analyst Sees 80% Upside in Micron Stock](https://longbridge.com/en/news/300340728.md)
- [Nvidia Drops Massive Number on Anthropic AI Spending](https://longbridge.com/en/news/300342358.md)
- [Satya Nadella Says Xbox Is on Track for a Comeback After Major Layoffs — ‘I Feel Fantastic’ About Its Gaming IP](https://longbridge.com/en/news/300308967.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**